Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cardiorespiratory Fitness Is Protective Against Alzheimer's and Related Disorders
Aging and Dementia
S15 - Aging and Dementia 1 (4:54 PM-5:06 PM)
008
Currently there are no known effective treatments to prevent or stop the progression of Alzheimer's Disease and Related Dementias. CRF is associated with favorable health outcomes. Thus, we examined the relationship between CRF measured using an exercise treadmill test (ETT) with incident AD/ADRD.
To evaluate the association between cardiorespiratory fitness (CRF) and the risk of developing Alzheimer's Disease and Related Disorders (ADRD).
Using the Veterans Health administration’s national electronic health record we identified 649,605 Veterans 30-95 years of age who completed standardized ETT between 2000-2017 and were free of ADRD at the time of the ETT. Natural language processing was used to extract metabolic equivalents (METs). We formed five age-specific fitness categories, lowest-fit (n=132,63; METs=3.8 ±), low-fit (n=129,493; METs=5.8 ±), moderate-fit (n=120,988; METs=7.5±,), fit (n=137,122; METs 9.2±) and highest-fit (n=129,368, METs=11.7±), based on peak METs achieved during the first ETT.
ADRD was identified using International Classification of Diseases (ICD) codes. Hazard ratios (HRs) and 95% confidence intervals (CIs) for incident ADRD during 8.8 years of average follow-up were estimated using lowest-fit group as the referent, adjusting for baseline characteristics.
The mean age of the participants was 61 years (standard deviation, 11). Of those, 5.7% were women and 16.6% African Americans. Unadjusted incident rates for ADRD were 9.5, 8.5, 7.4, 7.2 and 6.4 per 1,000 person-years for the lowest-fit to the highest-fit group, respectively (p<0.001). When compared to the lowest-fit group, multivariable adjusted HRs (95% CIs) for incident ADRD associated with low-, moderate-, high- and highest-fit groups were 0.87 (0.85-0.90; p<0.001), 0.80 (0.78-0.83; p<0.001), 0.74 (0.72-0.76; p<0.001) and 0.67 (0.65-0.70; p<0.001), respectively.
Our findings suggest that the association between CRF and ADRD risk is inverse, independent, and graded.
Authors/Disclosures
Edward Zamrini (Irvine Clinical Research)
PRESENTER
Dr. Zamrini has received personal compensation for serving as an employee of George Washington University. Dr. Zamrini has received personal compensation for serving as an employee of Irvine Clinical Research. Dr. Zamrini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Zamrini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Zamrini has received research support from NIH. The institution of Dr. Zamrini has received research support from NIH.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file